Suchergebnisse - "Mazza, Mario Gennaro"

PubPharm (50)

11

Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors

enthalten in: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 2022

von Poletti, S. | Paolini, M. | Mazza, M. | +5

12

Post-COVID-19 Depressive Symptoms : Epidemiology, Pathophysiology, and Pharmacological Treatment

enthalten in: CNS drugs | 2022

von Mazza, M. | Palladini, M. | Poletti, S. | +1

13

Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors : A comparison with major depressive disorder

enthalten in: Journal of affective disorders | 2022

von Benedetti, F. | Palladini, M. | D'Orsi, G. | +5

14

Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment

enthalten in: CNS drugs | 2022

von Mazza, M. | Palladini, M. | Poletti, S. | +1

15

Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment

enthalten in: CNS drugs | 2022

von Mazza, M. | Palladini, M. | Poletti, S. | +1

16

Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment

enthalten in: CNS drugs | 2022

von Mazza, M. | Palladini, M. | Poletti, S. | +1

17

Antipsychotics and COVID-19 Outcomes-The Potential Role of the Clinical Setting?

enthalten in: JAMA network open | 2022

von Vai, B. | Mazza, M.

CommentOn: JAMA Netw Open. 2022 May 2;5(5):e2210743. - PMID 35522282

18

Antidepressant psychopharmacology : is inflammation a future target?

enthalten in: International clinical psychopharmacology | 2022

von Benedetti, F. | Zanardi, R. | Mazza, M.

19

Machine learning approaches for prediction of bipolar disorder based on biological, clinical and neuropsychological markers : A systematic review and meta-analysis

enthalten in: Neuroscience and biobehavioral reviews | 2022

von Colombo, F. | Calesella, F. | Mazza, M. | +6

20

Comment on : "Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence"

enthalten in: Drugs | 2022

von Mazza, M. | Vai, B. | De Picker, L. | +2

CommentOn: Drugs. 2021 Dec;81(18):2081-2089. - PMID 34851510